LGX818是治療某些黑色素瘤的藥物。它是一個(gè)小分子BRAF抑制劑，靶向MAPK信號(hào)通路中的關(guān)鍵酶。
3-Amino-1-isopropyl-1H-pyrazole-4-carbonitrile
Ethoxymethylenemalononitrile
(S)-Methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Guanidine hydrochloride
3-Bromo-5-Chloro-2-fluorobenzoic acid
(S)-Methyl (1-aminopropan-2-yl)carbamate hydrochloride
3-Bromo-4-fluorochlorobenzene
4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)
tert-Butyl (5-chloro-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
tert-Butyl (3-bromo-5-chloro-2-fluorophenyl)carbamate
Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
2-Chloro-4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidine
Methyl (S)-(1-((4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
